Skip to content

Systematic review, 2012

How effective are cognitive-behavioral therapy and antidepressants for PMS and PMDD?

Both cognitive-behavioral therapy and serotonergic antidepressants showed small to medium effects, but researchers concluded efficacy was not satisfactory and recommend combining both approaches for better results.

Strong study design Women with premenstrual syndrome or premenstrual dysphoric disorder in 22 controlled trials

What they did

Meta-analysis of controlled trials comparing cognitive-behavioral therapy and serotonergic antidepressants for PMS or PMDD. Studies were selected according to pre-defined criteria, data extracted using standardized coding, and effect sizes calculated using random effects model.

What they found

22 studies included. Cognitive-behavioral interventions showed small to medium effect sizes (d+ ranging 0.24 to 0.70 at post-assessment, 0.46 to 0.74 at follow-up). Serotonergic antidepressants showed small to medium effect sizes (d+ ranging 0.29 to 0.58 at post-assessment). No evidence of publication bias.

What it means for you

While both treatments showed some benefit, the effects are modest. The researchers suggest neither treatment alone may be sufficient and propose that combining cognitive-behavioral therapy with serotonergic antidepressants might be more effective.

22

Controlled trials included

0.24-0.70

Cognitive-behavioral therapy effect size

0.29-0.58

Antidepressants effect size

About the study

Original title
Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis
Authors
Kleinstäuber M, Witthöft M, Hiller W
Journal
Journal of clinical psychology in medical settings
Year
2012
Study design
Systematic review
What was tested
Cognitive-behavioral therapy and/or serotonergic antidepressants

Topics